Published: 2020-04-30

Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

Funda Şimşek, The Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases*, Gökmen Zararsız, Faruk Karakeçili, Sami Kınıklı, Hüseyin Bilgin, Nesrin Türker, Gülden Ersöz, Ali Asan 0, Bilgehan Aygen, Reşit Mıstık, Ayşe Batırel, Onur Ural, Şener Barut, İlhami Çelik, Mustafa Kemal Çelen, Orhan Yıldız, Neşe Demirtürk

(305-317)

Endoscopic retrograde cholangiography via a permanent access loop

Mustafa Kaplan, Selçuk Dişibeyaz, Bülent Ödemiş, Erkan Parlak, Erkin Öztaş, Volkan Gökbulut

(318-323)

Validity and reliability analysis of the Turkish version of pediatric nutritional risk score scale

Onur Taşcı, Özlem Bekem Soylu, Ezgi Kıran Taşcı, Erhan Eser, Betül Oruçoğlu, İlker Günay

(324-330)

Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats

Chang-An Guo, Chang-An Guo, Chang-An Guo, Li Ma, Xiao-Lu Su, Ying-Zhen Wang, Ling-Ling Zhen, Bei Zhang, Hong An, Hong-Bin Liu

(331-341)